Globus Medical Inc.
GMED | NYSE
$79.08
+$1.03 (+1.32%)
Nov 2, 2026, 9:34 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 2.94B | 2.52B | 1.57B | 1.02B | 958.1M | 789.04M |
Cost of Revenue | 957.8M | 1.04B | 548.17M | 263.73M | 239.22M | 217.46M |
Gross Profit | 1.98B | 1.48B | 1.02B | 759.12M | 718.88M | 571.58M |
Operating Income | 479.8M | 165.99M | 133.14M | 227.95M | 171.95M | 111.43M |
Interest Income | 7.14M | n/a | 20.13M | 14.23M | 9.3M | 13.95M |
Pretax Income | 609.9M | 120.72M | 165.39M | 243.02M | 180.41M | 125.9M |
Net Income | 537.9M | 102.98M | 122.87M | 190.17M | 149.19M | 102.29M |
Selling & General & Admin | 1.32B | 981.05M | 643.41M | 432.12M | 408.15M | 354.76M |
Research & Development | 185M | 163.75M | 124.01M | 73.02M | 97.35M | 84.52M |
Other Expenses | n/a | 173.08M | 119.74M | 26.04M | 41.43M | 20.87M |
Operating Expenses | 1.5B | 1.32B | 887.16M | 531.17M | 546.93M | 460.15M |
Interest Expense | n/a | 4.19M | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.46B | 2.35B | 1.44B | 794.89M | 786.15M | 677.61M |
Income Tax Expense | 72M | 17.74M | 42.52M | 52.85M | 31.22M | 23.61M |
Shares Outstanding (Basic) | 135.15M | 135.73M | 113.09M | 100.47M | 100.73M | 98.58M |
Shares Outstanding (Diluted) | 137.22M | 137.86M | 114.63M | 102.64M | 103.62M | 100.97M |
EPS (Basic) | 3.98 | 0.76 | 1.09 | 1.89 | 1.48 | 1.04 |
EPS (Diluted) | 3.92 | 0.75 | 1.07 | 1.85 | 1.44 | 1.01 |
EBITDA | 729.9M | 473.73M | 346.58M | 304.5M | 264.73M | 178.35M |
EBIT | 609.9M | 219.7M | 201.85M | 236.25M | 194.86M | 115.47M |
Depreciation & Amortization | 120M | 254.02M | 144.73M | 68.25M | 69.87M | 62.87M |
Add to Watchlist
Select watchlists to add or remove GMED